TY  - GEN
AU  - Moreno-Smith,Myrthala
AU  - Lakoma,Anna
AU  - Chen,Zaowen
AU  - Tao,Ling
AU  - Scorsone,Kathleen A
AU  - Schild,Linda
AU  - Aviles-Padilla,Kevin
AU  - Nikzad,Rana
AU  - Zhang,Yankai
AU  - Chakraborty,Rikhia
AU  - Molenaar,Jan J
AU  - Vasudevan,Sanjeev A
AU  - Sheehan,Vivien
AU  - Kim,Eugene S
AU  - Paust,Silke
AU  - Shohet,Jason M
AU  - Barbieri,Eveline
TI  - p53 Nongenotoxic Activation and mTORC1 Inhibition Lead to Effective Combination for Neuroblastoma Therapy
SN  - 1557-3265
PY  - 2018///0723
KW  - Animals
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Apoptosis
KW  - drug effects
KW  - Cell Line, Tumor
KW  - Cell Proliferation
KW  - Drug Resistance, Neoplasm
KW  - genetics
KW  - Gene Expression Regulation, Neoplastic
KW  - Humans
KW  - Mechanistic Target of Rapamycin Complex 1
KW  - antagonists & inhibitors
KW  - Mice
KW  - Neuroblastoma
KW  - drug therapy
KW  - Proto-Oncogene Proteins c-mdm2
KW  - Pyrrolidines
KW  - Sirolimus
KW  - TOR Serine-Threonine Kinases
KW  - Tumor Suppressor Protein p53
KW  - Xenograft Model Antitumor Assays
KW  - para-Aminobenzoates
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1158/1078-0432.CCR-17-0668
ER  -